RankAlpha logo
Back to Rankings

OVID

Ovid TherapeuticsD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
OVID vs peer average
41/100
OVID vs. peer average (D vs. C)
Grade spread
A 2 · C 2 · D 5 · F 2
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

PRTA is the first available peer comparator.

Clinical-stage neurology biotech with event-driven valuation; useful as a loose comp for how pipeline timing and readout quality can drive sentiment in CNS names.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerPRTAProthena
OVID
Ovid Therapeutics
PRTA
Prothena
Grade
D
A
Momentum
93
39
Value
41
41
Sentiment
53
87
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive

Grade position vs PRTA

OVID / PRTA
Grade Position
Below peers
OVID vs. peer average (D vs. C)
41/100
Momentum
93
OVID
Value
41
OVID
Sentiment
53
PRTA

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs OVID
1
PRTA
PRTA
A
100/100
-3
2
RZLT
RZLT
D
40/100
Even
3
CCCC
CCCC
D
40/100
Even
4
EIKN
Eikon Therapeutics Inc Common
C
60/100
-1
5
OABI
OmniAb Inc Common
F
20/100
+1
PRTA is the first peer returned for this comparison set.